Introduction
Pineal region tumours are rare, comprising 0.4% to 1% of adult brain tumours. Despite its small size, the pineal gland is the origin of a surprisingly diverse array of tumour types. The three major categories are germ cell tumours, parenchymal cell tumours and the supporting tissue neoplasm, (glial tumour). Germinomas are the most common histological type, comprising 50%-60% of all pineal tumours. 1 Pineal parenchymal tumours represent about 30% of pineal region neoplasm. 2 The histogenesis of pineal parenchymal tumour is linked to the pineocytes, a cell with photosensory and neuroendocrine functions. Neoplasms derived from pineocytes or their embryonal precursors span a wide spectrum ranging from tumours composed of mature elements to ones composed of primitive, immature cells. Between these extremes are tumours demonstrating an intermediate degree of differentiation (PPTID). 3 PPTID was recognized in the 2007 WHO classification as a new pineal parenchymal neoplasm, intermediate in malignancy (WHO grade-II and III) between pineocytoma (grade-I) and pineoblastoma (grade-IV). It occurs at all ages, including childhood to adult life with a peak incidence in early adults. 3 There are very few reports about PPTID. So little is known about their clinical behavior and optimal management. 4, 5 Considering the above facts, we are presenting a case report of PPTID in Pulse Volume 6 (1 & 2) 2013
Discussion
PPTID comprises approximately 10% of all pineal parenchymal tumours. An accurate frequency of occurrence is unclear because of the diagnostic difficulties, both clinically and pathologically. 6, 7 The grading system of these tumours is also difficult and subjective. It has been suggested that a grading system based on mitotic activity and neurofilament protein immunoreactivity can differentiate low from high grade PPTID. 7 According to this new prognostic grading PPTID can be graded into four grades, Grade-I for pineocytoma, Grade-IV for pineoblastoma and Grade-II being defined as having less than six mitotic figures per 10 HPF, Positive immunolabelling of neurofilament, and Grade-III being defined as having six or more mitotic figure per 10 HPF and without immunostaining for neurofilament. 7 We present this case of PPTID to enrich current database of this tumour. Diagnosing PPTID can be difficult and histopatholigic findings are not pathognomic. Besides an accurate grading is essential for these rare tumours, because optimal therapeutic management and prognosis depend on histopathological grading. 2 
